STOCK TITAN

PTC Therapeutics to Present at the Cantor Virtual Global Healthcare Conference

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences

Rhea-AI Summary

PTC Therapeutics (NASDAQ: PTCT) will present a company overview at the Cantor Virtual Global Healthcare Conference on September 17, 2020, at 9:20 a.m. ET. The presentation will be available via live webcast on the PTC Therapeutics website, with an archive accessible for 30 days post-event. PTC focuses on developing innovative treatments for rare disorders, driving investment through a robust pipeline aimed at addressing unmet medical needs.

Loading...
Loading translation...
Argus Session date unavailable
-3.66% session move Open Argus
Details

News Market Reaction – PTCT

The recorded move for PTCT in the trading session of this news was -3.66%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

SOUTH PLAINFIELD, N.J., Sept. 3, 2020 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company overview at the Cantor Virtual Global Healthcare Conference on Thursday, September 17th at 9:20 a.m. ET.

The presentation will be webcast live on the Events and Presentations page under the investor relations section of PTC Therapeutics' website at www.ptcbio.com and will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection.

About PTC Therapeutics, Inc.
PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need.

FOR MORE INFORMATION PLEASE CONTACT:
Media & Investors:                                                          
Jane Baj                                                        
+1 (908) 912-9167                                     
jbaj@ptcbio.com                                        

 

Cision View original content:http://www.prnewswire.com/news-releases/ptc-therapeutics-to-present-at-the-cantor-virtual-global-healthcare-conference-301123388.html

SOURCE PTC Therapeutics, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will PTC present at the Cantor Virtual Global Healthcare Conference?

PTC Therapeutics will present on September 17, 2020, at 9:20 a.m. ET.

Where can I watch the PTC Therapeutics presentation?

The presentation can be viewed live on the PTC Therapeutics website under the investor relations section.

How long will the PTC presentation be available for viewing?

The webcast will be archived for 30 days after the presentation.

What is the focus of PTC Therapeutics?

PTC Therapeutics is focused on discovering, developing, and commercializing medicines for rare disorders.

What is the stock symbol for PTC Therapeutics?

The stock symbol for PTC Therapeutics is PTCT.

Keep reading